Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$70.57 USD
+0.20 (0.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $70.64 +0.07 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: AMC |
3/2024 | $1.13 | 0.00% |
Earnings Summary
For their last quarter, Ligand Pharmaceuticals (LGND) reported earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.58 per share. This reflects a positive earnings surprise of 81.03%. Look out for LGND's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of $1.13 per share, reflecting a year-over-year decrease of 50.44%.
Earnings History
Price & Consensus
Zacks News for LGND
BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
LGND: What are Zacks experts saying now?
Zacks Private Portfolio Services